Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Target CA125 peptides for cancer immunotherapy

Target CA125 peptides for cancer immunotherapy

US Patent 8097242 · Granted Jan 17, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of identifying patients responsive to immunotherapeutic strategies2021
Duocarmycin ADCs for use in treatment of endometrial cancer2018
Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine ca2017
Duocarmycin ADCs for use in treatment of endometrial cancer2016
Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine ca2014
Gene expression profiling in primary ovarian serous papillary tumors and normal 2013
Therapy with Clostridium perfringens enterotoxin to treat ovarian and uterine ca2012
Immunotherapeutic methods targeted toward stratum corneum chymotryptic enzyme2012
Methods for the early diagnosis of ovarian cancer2012
Methods for the early diagnosis of ovarian cancer2011
Gene expression profiling in primary ovarian serous papillary tumors and normal 2011
Methods for the early diagnosis of ovarian cancer2010